Qing-yi Y. Zhu

Jiangsu Key Laboratory Of Urological Disease Prevention And Treatment
Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

A novel lncRNA HUDRPC suppresses ferroptosis via the DDX5/DDIT3 pathway to promote docetaxel resistance in prostate cancer.

A novel lncRNA HUDRPC suppresses ferroptosis via the DDX5/DDIT3 pathway to promote docetaxel resistance in prostate cancer.

Journal: Cancer letters

Published: December 17, 2025

Analysis of transurethral water vapor thermal therapy for the treatment of benign prostatic hyperplasia

Analysis of transurethral water vapor thermal therapy for the treatment of benign prostatic hyperplasia

Journal: Zhonghua nan ke xue = National journal of andrology

Published: September 05, 2025

The application of full-length urethral preservation without anastomosis in single-port laparoscopic radical prostate cancer

The application of full-length urethral preservation without anastomosis in single-port laparoscopic radical prostate cancer

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: February 04, 2024

Robot-assisted single-port retroperitoneal partial nephrectomy with a novel purpose-built single-port robotic system with deformable surgical instruments.

Robot-assisted single-port retroperitoneal partial nephrectomy with a novel purpose-built single-port robotic system with deformable surgical instruments.

Journal: World journal of urology

Published: September 03, 2023

NCAPD3 promotes prostate cancer progression by up-regulating EZH2 and MALAT1 through STAT3 and E2F1.

NCAPD3 promotes prostate cancer progression by up-regulating EZH2 and MALAT1 through STAT3 and E2F1.

Journal: Cellular signalling

Published: October 23, 2021

Loss of a Negative Feedback Loop between IRF8 and AR Promotes Prostate Cancer Growth and Enzalutamide Resistance.

Loss of a Negative Feedback Loop between IRF8 and AR Promotes Prostate Cancer Growth and Enzalutamide Resistance.

Journal: Cancer research

Published: August 19, 2019

Clinical efficacy of integrated traditional Chinese and Western medicine for castration-resistant prostate cancer

Clinical efficacy of integrated traditional Chinese and Western medicine for castration-resistant prostate cancer

Journal: Zhonghua nan ke xue = National journal of andrology

Published: May 05, 2018

Chinese medicinal compound CFF-1 induces the apoptosis and cycle-arrest of prostate cancer cells via the PI3K/AKT/FOXO1 signaling pathway

Chinese medicinal compound CFF-1 induces the apoptosis and cycle-arrest of prostate cancer cells via the PI3K/AKT/FOXO1 signaling pathway

Journal: Zhonghua nan ke xue = National journal of andrology

Published: May 05, 2018

Depression promotes prostate cancer invasion and metastasis via a sympathetic-cAMP-FAK signaling pathway.

Depression promotes prostate cancer invasion and metastasis via a sympathetic-cAMP-FAK signaling pathway.

Journal: Oncogene

Published: September 25, 2017

Combination of sorafenib and enzalutamide as a potential new approach for the treatment of castration-resistant prostate cancer.

Combination of sorafenib and enzalutamide as a potential new approach for the treatment of castration-resistant prostate cancer.

Journal: Cancer letters

Published: July 28, 2016

Updated treatments of castration-resistant prostate cancer

Updated treatments of castration-resistant prostate cancer

Journal: Zhonghua nan ke xue = National journal of andrology

Published: July 16, 2016

Transurethral assistant transumbilical laparoendoscopic single-site radical prostatectomy.

Transurethral assistant transumbilical laparoendoscopic single-site radical prostatectomy.

Journal: Asian journal of andrology

Published: April 01, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026